Trial · NCT02098733
Adverse events27
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 27
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Oesophageal carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Pioglitazone/Glimepiride | 1 | 1,158 | |
| serious | Pancreatic carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Pioglitazone/Glimepiride | 1 | 1,158 | |
| serious | Lung neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Pioglitazone/Glimepiride | 1 | 1,158 | |
| serious | Prostate cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Pioglitazone/Glimepiride | 1 | 1,158 | |
| serious | Anaemia | Blood and lymphatic system disorders | Pioglitazone/Glimepiride | 1 | 1,158 | |
| serious | Hyperkalaemia | Metabolism and nutrition disorders | Pioglitazone/Glimepiride | 1 | 1,158 | |
| serious | Marasmus | Metabolism and nutrition disorders | Pioglitazone/Glimepiride | 1 | 1,158 | |
| serious | Completed suicide | Psychiatric disorders | Pioglitazone/Glimepiride | 1 | 1,158 | |
| serious | Cerebrovascular accident | Nervous system disorders | Pioglitazone/Glimepiride | 1 | 1,158 | |
| serious | Convulsion | Nervous system disorders | Pioglitazone/Glimepiride | 1 | 1,158 | |
| serious | Cardiac failure | Cardiac disorders | Pioglitazone/Glimepiride | 1 | 1,158 | |
| serious | Cardiac failure congestive | Cardiac disorders | Pioglitazone/Glimepiride | 1 | 1,158 | |
| serious | Mallory-Weiss syndrome | Gastrointestinal disorders | Pioglitazone/Glimepiride | 1 | 1,158 | |
| serious | Cholelithiasis | Hepatobiliary disorders | Pioglitazone/Glimepiride | 1 | 1,158 | |
| serious | Jaundice | Hepatobiliary disorders | Pioglitazone/Glimepiride | 1 | 1,158 | |
| serious | Bile duct obstruction | Hepatobiliary disorders | Pioglitazone/Glimepiride | 1 | 1,158 | |
| serious | Calculus ureteric | Renal and urinary disorders | Pioglitazone/Glimepiride | 1 | 1,158 | |
| serious | Nephrolithiasis | Renal and urinary disorders | Pioglitazone/Glimepiride | 1 | 1,158 | |
| serious | Renal failure | Renal and urinary disorders | Pioglitazone/Glimepiride | 1 | 1,158 | |
| serious | Death | General disorders | Pioglitazone/Glimepiride | 1 | 1,158 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02098733/events